Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| epithelial cell | 5 studies | 33% ± 11% | |
| B cell | 4 studies | 19% ± 2% | |
| endothelial cell | 4 studies | 26% ± 6% | |
| ciliated cell | 4 studies | 26% ± 4% | |
| dendritic cell | 3 studies | 27% ± 15% | |
| goblet cell | 3 studies | 18% ± 4% | |
| basal cell | 3 studies | 28% ± 8% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| peripheral blood | 3 studies | 24% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 2078.29 | 1445 / 1445 | 100% | 59.13 | 183 / 183 |
| liver | 100% | 1266.05 | 226 / 226 | 100% | 76.90 | 406 / 406 |
| ovary | 100% | 1336.44 | 180 / 180 | 100% | 97.30 | 430 / 430 |
| pancreas | 100% | 1347.53 | 328 / 328 | 100% | 87.58 | 178 / 178 |
| brain | 100% | 1862.58 | 2640 / 2642 | 100% | 124.48 | 705 / 705 |
| thymus | 100% | 1618.35 | 653 / 653 | 100% | 101.10 | 604 / 605 |
| uterus | 100% | 1584.76 | 170 / 170 | 100% | 104.44 | 457 / 459 |
| kidney | 100% | 1936.82 | 89 / 89 | 100% | 86.38 | 897 / 901 |
| skin | 100% | 2127.02 | 1809 / 1809 | 99% | 110.06 | 469 / 472 |
| stomach | 100% | 1659.35 | 359 / 359 | 99% | 78.53 | 284 / 286 |
| prostate | 100% | 1868.01 | 245 / 245 | 99% | 110.41 | 498 / 502 |
| adrenal gland | 100% | 1916.98 | 258 / 258 | 99% | 85.43 | 228 / 230 |
| intestine | 100% | 2132.96 | 966 / 966 | 99% | 90.90 | 521 / 527 |
| breast | 100% | 1812.94 | 459 / 459 | 99% | 92.95 | 1103 / 1118 |
| bladder | 100% | 2092.95 | 21 / 21 | 98% | 94.62 | 495 / 504 |
| lung | 100% | 1583.76 | 576 / 578 | 98% | 77.40 | 1136 / 1155 |
| adipose | 100% | 1896.86 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 100% | 140.76 | 80 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 129.13 | 29 / 29 |
| spleen | 100% | 1822.72 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 93.77 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 90.81 | 1 / 1 |
| blood vessel | 100% | 2032.35 | 1334 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 100% | 2021.42 | 801 / 803 | 0% | 0 | 0 / 0 |
| heart | 99% | 1769.16 | 855 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 97% | 1255.98 | 903 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0000154 | Biological process | rRNA modification |
| GO_0000455 | Biological process | enzyme-directed rRNA pseudouridine synthesis |
| GO_0030490 | Biological process | maturation of SSU-rRNA |
| GO_0005829 | Cellular component | cytosol |
| GO_1904047 | Molecular function | S-adenosyl-L-methionine binding |
| GO_0016740 | Molecular function | transferase activity |
| GO_0106388 | Molecular function | 18S rRNA aminocarboxypropyltransferase activity |
| Gene name | TSR3 |
| Protein name | TSR3 ribosome maturation factor 18S rRNA aminocarboxypropyltransferase (EC 2.5.1.-) (20S S rRNA accumulation protein 3 homolog) (HsTsr3) |
| Synonyms | C16orf42 UND313L |
| Description | FUNCTION: Aminocarboxypropyltransferase that catalyzes the aminocarboxypropyl transfer on pseudouridine at position 1248 (Psi1248) in 18S rRNA (Probable). It constitutes the last step in biosynthesis of the hypermodified N1-methyl-N3-(3-amino-3-carboxypropyl) pseudouridine (m1acp3-Psi) conserved in eukaryotic 18S rRNA (Probable). . |
| Accessions | ENST00000566296.1 H3BQD4 ENST00000007390.3 Q9UJK0 |
